Antiva Biosciences, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Antiva Biosciences, Inc.
Quantité totale PI 12
Rang # Quantité totale PI 129 999
Note d'activité PI 2,1/5.0    15
Rang # Activité PI 56 673
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

4 2
1 0
5 0
0
 
Dernier brevet 2025 - Compositions and dosage forms fo...
Premier brevet 2023 - Compositions and dosage forms fo...
Dernière marque 2015 - ANTIVA
Première marque 2015 - ANTIVA

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Compositions and dosage forms for treatment of hpv infection and hpv-induced neoplasia. A pharma...
Invention Synthesis of ethyl-2-((((2-(2-amino-6-methoxy-9h-purin-9-yl)-ethoxy)-methyl)-(benzyloxy)-phosphor...
Invention Advantageous compounds for treatment of hpv infection and hpv-induced neoplasia. The present disc...
Invention Device system and use for hpv infection and cervical intraepithelial neoplasia. The disclosure re...
2024 Invention Device system and use for hpv infection and cervical intraepithelial neoplasia. A pharmaceuticall...
2023 Invention Compositions and dosage forms for treatment of hpv infection and hpv-induced neoplasia. A pharmac...
Invention Treatment of hpv infection. A pharmaceutically acceptable salt of an acyclic nucleotide phosphor...
Invention Treatment of hpv-induced neoplasia. A pharmaceutically acceptable salt of an acyclic nucleotide ...
2015 P/S antivirals; pharmaceutical preparations, namely, antivirals; pharmaceutical preparations to inhib...